SARS-COV2 INFECTION
Clinical trials for SARS-COV2 INFECTION explained in plain language.
Never miss a new study
Get alerted when new SARS-COV2 INFECTION trials appear
Sign up with your email to follow new studies for SARS-COV2 INFECTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New COVID booster shows promise in trial
⭐️ VACCINE ⭐️ CompletedThis study tested a new booster vaccine for COVID-19 in 913 adults who had already received initial vaccines and at least one booster. The goal was to see if the new booster is safe and triggers a strong immune response against newer virus variants. Participants received either t…
Matched conditions: SARS-COV2 INFECTION
Phase: PHASE2, PHASE3 • Sponsor: Hipra Scientific, S.L.U • Aim: ⭐️ VACCINE ⭐️
Last updated May 26, 2026 06:50 UTC
-
Massive study tracks 15,000 adults to uncover long COVID mysteries
Knowledge-focused CompletedThis study followed over 15,000 adults with and without COVID-19 to learn why some people develop Long COVID (ongoing symptoms like fatigue or brain fog). Researchers collected health data and blood samples over time to identify risk factors and patterns. The goal is to better un…
Matched conditions: SARS-COV2 INFECTION
Sponsor: NYU Langone Health • Aim: Knowledge-focused
Last updated May 26, 2026 06:52 UTC
-
Paris shelter study reveals hidden COVID-19 spread among homeless
Knowledge-focused CompletedThis study looked at how many people in homeless shelters and their workers in Paris had COVID-19 antibodies after the first wave. About 179 adults from three shelters took part. The goal was to understand infection rates and risks in this vulnerable group, without offering any t…
Matched conditions: SARS-COV2 INFECTION
Sponsor: Institut National de la Santé Et de la Recherche Médicale, France • Aim: Knowledge-focused
Last updated May 26, 2026 06:51 UTC
-
COVID-19 drug study explores immune cell changes
Knowledge-focused CompletedThis study looked at how phenelzine, a monoamine oxidase inhibitor, changes the activity of immune cells in people with COVID-19. Researchers measured specific markers on T cells and monocytes to see if the drug alters immune activation. The study involved 51 adults with confirme…
Matched conditions: SARS-COV2 INFECTION
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated May 26, 2026 06:45 UTC